Michel Vounatsos
2019
Compensation breakdown
Change in Pension Value and Nonqualified Deferred Compensation Earnings | $85,667 |
---|---|
Non-Equity Incentive Plan | $3,884,000 |
Salary | $1,388,461 |
Stock Awards | $12,352,030 |
Other | $449,700 |
Total | $18,159,858 |
Vounatsos received $12.4M in stock awards, accounting for 68% of the total pay in 2019.
Vounatsos also received $85.7K of change in pension value and nonqualified deferred compensation earnings, $3.9M in non-equity incentive plan, $1.4M in salary and $449.7K in other compensation.
Rankings
In 2019, Michel Vounatsos' compensation ranked 215th out of 13,971 executives tracked by ExecPay. In other words, Vounatsos earned more than 98.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 215 | 99th |
Manufacturing | 78 | 99th |
Chemicals And Allied Products | 21 | 99th |
Drugs | 17 | 99th |
Biological Products, Except Diagnostic Substances | 2 | 100th |
Pay ratio
Michel Vounatsos' Pay | $18,159,858 |
---|---|
Median Employee's Pay | $159,721 |
Pay Ratio | 114to 1 |
In 2019, the annual total compensation of Michel Vounatsos was $18,159,858.
The annual total compensation of the median employee at Biogen was $159,721.
The ratio of Michel Vounatsos' pay to the pay of median employee was therefore 114 to one.
Vounatsos' colleagues
We found five more compensation records of executives who worked with Michel Vounatsos at Biogen in 2019.
2019
Jeffrey Capello
Biogen
Chief Financial Officer
2019
Susan Alexander
Biogen
Chief Legal Officer
2019
Alfred Sandrock
Biogen
Executive Vice President, Research & Development
2019
Michael Ehlers
Biogen
Former Executive Vice President Research Development
2019
Chirfi Guindo
Biogen